THE CYTOKINE
Interleukin-6 is a signaling protein the immune system releases during infection and inflammation. It crosses the placenta and the fetal blood-brain barrier, where it disrupts the developing white matter — the wiring that lets brain regions talk to each other.
CHORIOAMNIONITIS
Infection of the membranes surrounding the fetus is the single largest driver of spontaneous preterm birth. It is often silent — the mother has no fever, no pain — but the fetus is bathed in inflammatory cytokines for days before delivery.
WHY THE BRAIN IS VULNERABLE
Before 32 weeks, the fetal brain is in a critical window of oligodendrocyte maturation — the cells that make myelin. These precursor cells are uniquely sensitive to inflammation; damage during this window causes periventricular leukomalacia, the lesion underlying most cases of cerebral palsy in preterm survivors.
THE LINEAR ASSUMPTION
Most clinical screening assumes a dose-response curve — twice the biomarker, roughly twice the risk. Linear regression is the default tool in epidemiology because it is simple, interpretable, and usually close enough. Biology disagrees more often than the literature admits: thresholds, plateaus, and inflection points are common, and a linear cutoff drawn through a nonlinear curve systematically misranks the extremes.
THE REFERENCE-RANGE PROBLEM
Clinical cutoffs are usually derived from the population the original study ran in — often white European or North American cohorts. Baseline inflammatory tone, infection burden, and genetic variants in cytokine signaling differ across populations, so a threshold calibrated in Boston can systematically misclassify infants in Shenyang, Lagos, or Karachi.
THE BURDEN
Roughly one in ten births globally is preterm, and preterm complications are the leading cause of death in children under five. Sub-Saharan Africa and South Asia carry the largest absolute share — the same regions where neonatal units are most likely to import Western screening protocols without local recalibration.